Screening existing drugs for neurodegeneration: The National Institute of Neurologic Disorders and Stroke (NINDS) model.
Heemskerk
Jill
J
Technology Development at the NINDS and Spinal Muscular Atrophy Project and the NINDS High-Throughput Drug Screening Facility for Neurodegeneration, USA.
D000818:Animals; D015195:Drug Design; D004353:Drug Evaluation, Preclinical / Q000379:methods*; D006801:Humans; D008954:Models, Biological; D009316:National Institutes of Health (U.S.); D009422:Nervous System Diseases / Q000188:drug therapy*; D014481:United States